MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8...

por Østergaard, M, Jacobsson, L T H, Schaufelberger, C, Hansen, M Sejer, Bijlsma, J W J, Dudek, A, Rell-Bakalarska, M, Staelens, F, Haake, R, Sundman-Engberg, B, Bliddal, H
Publicado 2015